

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 8.43733643 |
| 2 | muscle filament sliding (GO:0030049) | 8.43733643 |
| 3 | * sarcomere organization (GO:0045214) | 8.18495408 |
| 4 | cardiac myofibril assembly (GO:0055003) | 7.80735229 |
| 5 | myofibril assembly (GO:0030239) | 7.08709642 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.82044436 |
| 7 | cardiac muscle cell development (GO:0055013) | 6.46901001 |
| 8 | cardiac muscle contraction (GO:0060048) | 6.36770189 |
| 9 | heart process (GO:0003015) | 6.23140666 |
| 10 | heart contraction (GO:0060047) | 6.23140666 |
| 11 | cardiac cell development (GO:0055006) | 6.13529798 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 5.97257804 |
| 13 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.96022741 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.93913823 |
| 15 | oxidative phosphorylation (GO:0006119) | 5.54444779 |
| 16 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.51558679 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 5.51558679 |
| 18 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.48613376 |
| 19 | regulation of skeletal muscle contraction (GO:0014819) | 5.42924106 |
| 20 | regulation of relaxation of muscle (GO:1901077) | 5.32783253 |
| 21 | muscle tissue morphogenesis (GO:0060415) | 5.32155640 |
| 22 | striated muscle contraction (GO:0006941) | 5.18880366 |
| 23 | cardiac muscle hypertrophy (GO:0003300) | 5.17866942 |
| 24 | * actomyosin structure organization (GO:0031032) | 5.12556037 |
| 25 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.97932830 |
| 26 | actin filament-based movement (GO:0030048) | 4.93165184 |
| 27 | striated muscle hypertrophy (GO:0014897) | 4.87018635 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.86505335 |
| 29 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.84910447 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.84023761 |
| 31 | respiratory electron transport chain (GO:0022904) | 4.82029074 |
| 32 | adult heart development (GO:0007512) | 4.77706956 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.72008987 |
| 34 | regulation of actin filament-based movement (GO:1903115) | 4.70344155 |
| 35 | electron transport chain (GO:0022900) | 4.68169780 |
| 36 | muscle hypertrophy (GO:0014896) | 4.67049139 |
| 37 | NADH metabolic process (GO:0006734) | 4.66927830 |
| 38 | regulation of sarcomere organization (GO:0060297) | 4.57911303 |
| 39 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.30646420 |
| 40 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.30639318 |
| 41 | ventricular cardiac muscle cell development (GO:0055015) | 4.29859473 |
| 42 | heart trabecula formation (GO:0060347) | 4.28183573 |
| 43 | regulation of the force of heart contraction (GO:0002026) | 4.24128755 |
| 44 | plasma membrane repair (GO:0001778) | 4.21756093 |
| 45 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.12734306 |
| 46 | cytidine metabolic process (GO:0046087) | 4.09761457 |
| 47 | cytidine catabolic process (GO:0006216) | 4.09761457 |
| 48 | cytidine deamination (GO:0009972) | 4.09761457 |
| 49 | pinocytosis (GO:0006907) | 4.08160186 |
| 50 | regulation of ATP catabolic process (GO:1903289) | 3.92106543 |
| 51 | regulation of ATPase activity (GO:0043462) | 3.92106543 |
| 52 | ubiquinone biosynthetic process (GO:0006744) | 3.90941327 |
| 53 | quinone biosynthetic process (GO:1901663) | 3.90941327 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.90693397 |
| 55 | purine nucleotide salvage (GO:0032261) | 3.90118277 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 3.83435506 |
| 57 | regulation of cofactor metabolic process (GO:0051193) | 3.81123592 |
| 58 | regulation of coenzyme metabolic process (GO:0051196) | 3.81123592 |
| 59 | nucleotide salvage (GO:0043173) | 3.81021724 |
| 60 | adenosine receptor signaling pathway (GO:0001973) | 3.79666588 |
| 61 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.78570938 |
| 62 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.74820855 |
| 63 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.74820855 |
| 64 | NADH dehydrogenase complex assembly (GO:0010257) | 3.74820855 |
| 65 | regulation of cardioblast differentiation (GO:0051890) | 3.73371654 |
| 66 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.72417066 |
| 67 | striated muscle cell development (GO:0055002) | 3.70647630 |
| 68 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.60535636 |
| 69 | regulation of cell communication by electrical coupling (GO:0010649) | 3.57717683 |
| 70 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.57332625 |
| 71 | oxaloacetate metabolic process (GO:0006107) | 3.51192408 |
| 72 | cardiac muscle adaptation (GO:0014887) | 3.47136328 |
| 73 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.47136328 |
| 74 | muscle hypertrophy in response to stress (GO:0003299) | 3.47136328 |
| 75 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.45626854 |
| 76 | skeletal muscle contraction (GO:0003009) | 3.42110866 |
| 77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.42038078 |
| 78 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.41478220 |
| 79 | ATP biosynthetic process (GO:0006754) | 3.39828416 |
| 80 | response to muscle activity (GO:0014850) | 3.39366967 |
| 81 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38648295 |
| 82 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.38166939 |
| 83 | ubiquinone metabolic process (GO:0006743) | 3.37627103 |
| 84 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.36871990 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 3.30916337 |
| 86 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.30691356 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.28636492 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 3.25590317 |
| 89 | protein complex biogenesis (GO:0070271) | 3.24540487 |
| 90 | muscle contraction (GO:0006936) | 3.22874437 |
| 91 | oligosaccharide catabolic process (GO:0009313) | 3.16352921 |
| 92 | carnitine shuttle (GO:0006853) | 3.13644945 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.13025977 |
| 94 | regulation of cholesterol storage (GO:0010885) | 3.12356384 |
| 95 | regulation of mitochondrial translation (GO:0070129) | 3.11420944 |
| 96 | muscle cell development (GO:0055001) | 3.10387708 |
| 97 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.09843949 |
| 98 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.09182825 |
| 99 | regulation of sequestering of triglyceride (GO:0010889) | 3.07121414 |
| 100 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.04173868 |
| 101 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.04173868 |
| 102 | aerobic respiration (GO:0009060) | 3.02597522 |
| 103 | response to peptidoglycan (GO:0032494) | 3.02153360 |
| 104 | galactose catabolic process (GO:0019388) | 3.01980593 |
| 105 | muscle system process (GO:0003012) | 3.01664509 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00325988 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00325988 |
| 108 | cellular response to arsenic-containing substance (GO:0071243) | 2.98131893 |
| 109 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.94565285 |
| 110 | cellular respiration (GO:0045333) | 2.90757292 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90667462 |
| 112 | regulation of heart rate (GO:0002027) | 2.89834995 |
| 113 | glycolipid catabolic process (GO:0019377) | 2.87326710 |
| 114 | positive regulation of protein homodimerization activity (GO:0090073) | 2.86874688 |
| 115 | regulation of mononuclear cell migration (GO:0071675) | 2.86700672 |
| 116 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.86351663 |
| 117 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.85203335 |
| 118 | low-density lipoprotein particle clearance (GO:0034383) | 2.84831168 |
| 119 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.84189947 |
| 120 | glycolytic process (GO:0006096) | 2.82771581 |
| 121 | negative regulation of cell size (GO:0045792) | 2.82263421 |
| 122 | negative regulation of monooxygenase activity (GO:0032769) | 2.81925484 |
| 123 | positive regulation of myotube differentiation (GO:0010831) | 2.81720844 |
| 124 | trabecula formation (GO:0060343) | 2.81061574 |
| 125 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.80516999 |
| 126 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.79457297 |
| 127 | creatine metabolic process (GO:0006600) | 2.79106132 |
| 128 | autophagic vacuole fusion (GO:0000046) | 2.77458899 |
| 129 | regulation of muscle contraction (GO:0006937) | 2.77014890 |
| 130 | regulation of membrane repolarization (GO:0060306) | 2.76390265 |
| 131 | protein insertion into membrane (GO:0051205) | 2.72711501 |
| 132 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72465623 |
| 133 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.71431140 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.71045009 |
| 135 | sphingolipid catabolic process (GO:0030149) | 2.70835663 |
| 136 | deoxyribonucleotide catabolic process (GO:0009264) | 2.70125279 |
| 137 | cyclooxygenase pathway (GO:0019371) | 2.69960823 |
| 138 | regulation of immunoglobulin secretion (GO:0051023) | 2.69930357 |
| 139 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.69364645 |
| 140 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.68754054 |
| 141 | low-density lipoprotein particle remodeling (GO:0034374) | 2.66253109 |
| 142 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.65781291 |
| 143 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65719093 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 2.64802261 |
| 145 | membrane lipid catabolic process (GO:0046466) | 2.63415191 |
| 146 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62857962 |
| 147 | deoxyribose phosphate catabolic process (GO:0046386) | 2.61058029 |
| 148 | ceramide catabolic process (GO:0046514) | 2.58913270 |
| 149 | regulation of chemokine biosynthetic process (GO:0045073) | 2.58651152 |
| 150 | folic acid transport (GO:0015884) | 2.56858769 |
| 151 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.56474740 |
| 152 | activation of MAPKKK activity (GO:0000185) | 2.56153236 |
| 153 | UV protection (GO:0009650) | 2.55522126 |
| 154 | regulation of penile erection (GO:0060405) | 2.55231948 |
| 155 | positive regulation of heat generation (GO:0031652) | 2.54821635 |
| 156 | germinal center formation (GO:0002467) | 2.49613749 |
| 157 | mitochondrial genome maintenance (GO:0000002) | 2.48246636 |
| 158 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.47662606 |
| 159 | amino sugar catabolic process (GO:0046348) | 2.47659538 |
| 160 | adhesion of symbiont to host (GO:0044406) | 2.46738231 |
| 161 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.46582740 |
| 162 | N-acetylneuraminate metabolic process (GO:0006054) | 2.46440860 |
| 163 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45839579 |
| 164 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.44613810 |
| 165 | pentose-phosphate shunt (GO:0006098) | 2.44551764 |
| 166 | skeletal muscle fiber development (GO:0048741) | 2.43538567 |
| 167 | regulation of fever generation (GO:0031620) | 2.43212881 |
| 168 | NADPH regeneration (GO:0006740) | 2.41641569 |
| 169 | complement activation, alternative pathway (GO:0006957) | 2.41400903 |
| 170 | regulation of mitochondrial membrane potential (GO:0051881) | 2.39997098 |
| 171 | response to thyroid hormone (GO:0097066) | 2.39397486 |
| 172 | positive regulation of prostaglandin secretion (GO:0032308) | 2.38813033 |
| 173 | mitochondrial fusion (GO:0008053) | 2.37965218 |
| 174 | plasma lipoprotein particle clearance (GO:0034381) | 2.37497133 |
| 175 | endosome to melanosome transport (GO:0035646) | 2.37230870 |
| 176 | endosome to pigment granule transport (GO:0043485) | 2.37230870 |
| 177 | negative regulation of cation channel activity (GO:2001258) | 2.36761008 |
| 178 | skeletal muscle tissue regeneration (GO:0043403) | 2.35781366 |
| 179 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34441242 |
| 180 | purine-containing compound salvage (GO:0043101) | 2.34340771 |
| 181 | monosaccharide biosynthetic process (GO:0046364) | 2.33216241 |
| 182 | lysosome organization (GO:0007040) | 2.32515795 |
| 183 | lytic vacuole organization (GO:0080171) | 2.32515795 |
| 184 | negative regulation of interleukin-12 production (GO:0032695) | 2.32197435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.40033631 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.22769353 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46571645 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.45451645 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.42641921 |
| 6 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.38851427 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.36638097 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.99736569 |
| 9 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.98910483 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.97347619 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.94873304 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.89350480 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.87252714 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85610464 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.53320270 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.45834727 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.38458737 |
| 18 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.38044283 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30209475 |
| 20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.20975184 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.17095757 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14965638 |
| 23 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.13296119 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.05607616 |
| 25 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02377730 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00387379 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.98913199 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.98310220 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89709681 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.80675104 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78874843 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78438687 |
| 33 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.78154848 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.78021215 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.78021215 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76668453 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76616736 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.75655118 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75335552 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.73987670 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.73898142 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73324406 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69288203 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67500206 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.66980104 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66400307 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66326994 |
| 48 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.66020717 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65536928 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64473291 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63362350 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62746265 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60946782 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57254945 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56294118 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.55525494 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55018869 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53905453 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53258462 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51860393 |
| 61 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.49586361 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.47832689 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46571562 |
| 64 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46136030 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42483070 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42354714 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41014958 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40363535 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39720496 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39518297 |
| 71 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38031119 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37442064 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36056663 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.35014577 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32485193 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31860850 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30465448 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29506730 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.29209866 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28858079 |
| 81 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27685600 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26616307 |
| 83 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.25641719 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.24744722 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24577550 |
| 86 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.24413064 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.24302877 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23383347 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22317432 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21925507 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20981788 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20547616 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20538581 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20259698 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20042784 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19711081 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19472786 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18836337 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18644152 |
| 100 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18241638 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17965839 |
| 102 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17594174 |
| 103 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17105966 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16676837 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15784904 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.15759264 |
| 107 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15709835 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15362817 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14662277 |
| 110 | MAF_26560356_Chip-Seq_TH1_Human | 1.14170086 |
| 111 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14113963 |
| 112 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.13270640 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12497948 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11796234 |
| 115 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11681114 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11614580 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11127942 |
| 118 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10169980 |
| 119 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.10060308 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08454946 |
| 121 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07950377 |
| 122 | MYC_22102868_ChIP-Seq_BL_Human | 1.06512083 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06364613 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05854614 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04362886 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03144462 |
| 127 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02631901 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02043204 |
| 129 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01479454 |
| 130 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00555711 |
| 131 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00354611 |
| 132 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99953667 |
| 133 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99279182 |
| 134 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97516599 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97211711 |
| 136 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.93548678 |
| 137 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92532682 |
| 138 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91886534 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91466632 |
| 140 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91305408 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90838637 |
| 142 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90800805 |
| 143 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90710622 |
| 144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89990493 |
| 145 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89768719 |
| 146 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89670411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 5.52649755 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.46783220 |
| 3 | MP0003646_muscle_fatigue | 4.93907104 |
| 4 | MP0000749_muscle_degeneration | 4.79899172 |
| 5 | MP0000751_myopathy | 4.32958956 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.20716765 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.98389282 |
| 8 | MP0005330_cardiomyopathy | 3.72655470 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.36233783 |
| 10 | MP0002972_abnormal_cardiac_muscle | 3.02778085 |
| 11 | MP0008775_abnormal_heart_ventricle | 2.99500067 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.91427734 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.86163630 |
| 14 | MP0003303_peritoneal_inflammation | 2.81612929 |
| 15 | MP0004510_myositis | 2.74032116 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.59748134 |
| 17 | MP0003221_abnormal_cardiomyocyte_apopto | 2.53793135 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.52657362 |
| 19 | MP0002269_muscular_atrophy | 2.47753424 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.40617191 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.40170179 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.40170179 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 2.31904713 |
| 24 | MP0006138_congestive_heart_failure | 2.28954594 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.25985732 |
| 26 | MP0003137_abnormal_impulse_conducting | 2.23839323 |
| 27 | MP0003828_pulmonary_edema | 2.20303652 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 2.16948202 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.15662004 |
| 30 | MP0005451_abnormal_body_composition | 2.09984603 |
| 31 | MP0000747_muscle_weakness | 2.01736118 |
| 32 | MP0005369_muscle_phenotype | 1.97413295 |
| 33 | MP0004484_altered_response_of | 1.97022119 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.96691720 |
| 35 | * MP0000759_abnormal_skeletal_muscle | 1.88896633 |
| 36 | MP0002254_reproductive_system_inflammat | 1.85722530 |
| 37 | MP0009278_abnormal_bone_marrow | 1.83881654 |
| 38 | MP0004130_abnormal_muscle_cell | 1.82950507 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.81136254 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.81136254 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.78414689 |
| 42 | MP0004085_abnormal_heartbeat | 1.74509105 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 1.73576660 |
| 44 | MP0004233_abnormal_muscle_weight | 1.64674798 |
| 45 | MP0003279_aneurysm | 1.64090252 |
| 46 | MP0009764_decreased_sensitivity_to | 1.63562593 |
| 47 | MP0003075_altered_response_to | 1.62130875 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 1.53086883 |
| 49 | MP0003436_decreased_susceptibility_to | 1.52132354 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.51247554 |
| 51 | MP0005670_abnormal_white_adipose | 1.49390375 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.48668761 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.42871975 |
| 54 | MP0002419_abnormal_innate_immunity | 1.42735492 |
| 55 | MP0009785_altered_susceptibility_to | 1.41764536 |
| 56 | MP0005310_abnormal_salivary_gland | 1.40614898 |
| 57 | MP0000858_altered_metastatic_potential | 1.38648777 |
| 58 | MP0000343_altered_response_to | 1.34656409 |
| 59 | MP0006082_CNS_inflammation | 1.29023285 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.28256363 |
| 61 | MP0005360_urolithiasis | 1.26287899 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.22834476 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.22666222 |
| 64 | MP0008469_abnormal_protein_level | 1.21003990 |
| 65 | MP0005025_abnormal_response_to | 1.18615114 |
| 66 | MP0005387_immune_system_phenotype | 1.17159741 |
| 67 | MP0001790_abnormal_immune_system | 1.17159741 |
| 68 | MP0000604_amyloidosis | 1.14795035 |
| 69 | MP0000266_abnormal_heart_morphology | 1.09149010 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.07750567 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.04537337 |
| 72 | MP0004147_increased_porphyrin_level | 1.03834151 |
| 73 | MP0005365_abnormal_bile_salt | 0.99878507 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.99623401 |
| 75 | MP0006054_spinal_hemorrhage | 0.96828781 |
| 76 | MP0008004_abnormal_stomach_pH | 0.95273053 |
| 77 | MP0000685_abnormal_immune_system | 0.95112769 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.93362207 |
| 79 | MP0009840_abnormal_foam_cell | 0.91976223 |
| 80 | MP0001661_extended_life_span | 0.90758566 |
| 81 | MP0002452_abnormal_antigen_presenting | 0.90412348 |
| 82 | MP0002653_abnormal_ependyma_morphology | 0.89862876 |
| 83 | MP0008260_abnormal_autophagy | 0.89232048 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.89133441 |
| 85 | MP0008874_decreased_physiological_sensi | 0.88806880 |
| 86 | MP0002971_abnormal_brown_adipose | 0.86262949 |
| 87 | MP0001849_ear_inflammation | 0.85402617 |
| 88 | MP0002723_abnormal_immune_serum | 0.84369784 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.84172613 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.84019705 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.82356720 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.81040641 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.80600915 |
| 94 | MP0003448_altered_tumor_morphology | 0.79157916 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.78568647 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.78165262 |
| 97 | MP0005266_abnormal_metabolism | 0.77303319 |
| 98 | MP0009763_increased_sensitivity_to | 0.76609763 |
| 99 | MP0002128_abnormal_blood_circulation | 0.75532767 |
| 100 | MP0003984_embryonic_growth_retardation | 0.75321602 |
| 101 | MP0004858_abnormal_nervous_system | 0.75253899 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 0.75009500 |
| 103 | MP0005166_decreased_susceptibility_to | 0.74526759 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74438454 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.74338939 |
| 106 | MP0003186_abnormal_redox_activity | 0.73512224 |
| 107 | MP0000609_abnormal_liver_physiology | 0.72227815 |
| 108 | MP0002090_abnormal_vision | 0.71717856 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.69007289 |
| 110 | MP0003195_calcinosis | 0.67803755 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.65877434 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.65354535 |
| 113 | MP0005165_increased_susceptibility_to | 0.65342021 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.64721622 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.64134211 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.60901670 |
| 117 | MP0001730_embryonic_growth_arrest | 0.57346295 |
| 118 | MP0010094_abnormal_chromosome_stability | 0.57028391 |
| 119 | MP0000358_abnormal_cell_content/ | 0.57008562 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.56661861 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.54749469 |
| 122 | MP0005380_embryogenesis_phenotype | 0.51807728 |
| 123 | MP0001672_abnormal_embryogenesis/_devel | 0.51807728 |
| 124 | MP0000733_abnormal_muscle_development | 0.50914068 |
| 125 | MP0001614_abnormal_blood_vessel | 0.50486337 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.50483555 |
| 127 | MP0001853_heart_inflammation | 0.49336704 |
| 128 | MP0003693_abnormal_embryo_hatching | 0.47951827 |
| 129 | MP0002925_abnormal_cardiovascular_devel | 0.43995777 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.43151234 |
| 131 | MP0009697_abnormal_copulation | 0.43074984 |
| 132 | MP0003718_maternal_effect | 0.42245466 |
| 133 | MP0008007_abnormal_cellular_replicative | 0.41167119 |
| 134 | MP0001697_abnormal_embryo_size | 0.39661507 |
| 135 | MP0005376_homeostasis/metabolism_phenot | 0.38424949 |
| 136 | MP0000249_abnormal_blood_vessel | 0.37677144 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.37156897 |
| 138 | MP0008058_abnormal_DNA_repair | 0.35808308 |
| 139 | MP0010368_abnormal_lymphatic_system | 0.35273957 |
| 140 | MP0003077_abnormal_cell_cycle | 0.35073090 |
| 141 | MP0002080_prenatal_lethality | 0.33879265 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.33395695 |
| 143 | MP0005257_abnormal_intraocular_pressure | 0.32600383 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.32421426 |
| 145 | MP0001764_abnormal_homeostasis | 0.32398746 |
| 146 | MP0009672_abnormal_birth_weight | 0.31913327 |
| 147 | MP0005623_abnormal_meninges_morphology | 0.31576703 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31335777 |
| 149 | MP0000598_abnormal_liver_morphology | 0.31001969 |
| 150 | MP0003123_paternal_imprinting | 0.29593772 |
| 151 | MP0002132_abnormal_respiratory_system | 0.29549814 |
| 152 | MP0004957_abnormal_blastocyst_morpholog | 0.29173540 |
| 153 | MP0001784_abnormal_fluid_regulation | 0.28145365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 7.53680632 |
| 2 | Sudden death (HP:0001699) | 6.44796001 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.41653170 |
| 4 | Ventricular tachycardia (HP:0004756) | 6.11382663 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.92033372 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.45999915 |
| 7 | Myoglobinuria (HP:0002913) | 4.90957691 |
| 8 | Lipoatrophy (HP:0100578) | 4.89146963 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 4.82714729 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.70862141 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.70862141 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.70862141 |
| 13 | Atrial fibrillation (HP:0005110) | 4.69723413 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.57357428 |
| 15 | Subaortic stenosis (HP:0001682) | 4.48675011 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.48675011 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 4.37456207 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.37240790 |
| 19 | Supraventricular tachycardia (HP:0004755) | 4.35691749 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.32722005 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.26208389 |
| 22 | Dilated cardiomyopathy (HP:0001644) | 4.21211489 |
| 23 | Hepatic necrosis (HP:0002605) | 4.15318517 |
| 24 | Hepatocellular necrosis (HP:0001404) | 4.11783371 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 4.11538817 |
| 26 | Acute necrotizing encephalopathy (HP:0006965) | 4.05749748 |
| 27 | Palpitations (HP:0001962) | 4.03769101 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.98964835 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.81342464 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.75691719 |
| 31 | Mitochondrial inheritance (HP:0001427) | 3.74537049 |
| 32 | Myopathic facies (HP:0002058) | 3.71519684 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.70267018 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.69647732 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.65235014 |
| 36 | Acute encephalopathy (HP:0006846) | 3.62080307 |
| 37 | Increased CSF lactate (HP:0002490) | 3.55157373 |
| 38 | Exercise intolerance (HP:0003546) | 3.32836478 |
| 39 | Progressive macrocephaly (HP:0004481) | 3.28926300 |
| 40 | Syncope (HP:0001279) | 3.24223054 |
| 41 | Ventricular arrhythmia (HP:0004308) | 3.20523423 |
| 42 | Increased connective tissue (HP:0009025) | 3.18113462 |
| 43 | Abnormality of glycolysis (HP:0004366) | 3.17466631 |
| 44 | Increased serum pyruvate (HP:0003542) | 3.17466631 |
| 45 | Dysostosis multiplex (HP:0000943) | 3.14880910 |
| 46 | Distal arthrogryposis (HP:0005684) | 3.13818679 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 3.10607339 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.04865848 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 3.02888098 |
| 50 | Bundle branch block (HP:0011710) | 2.97331748 |
| 51 | Myotonia (HP:0002486) | 2.97146085 |
| 52 | Complement deficiency (HP:0004431) | 2.92531839 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.89234769 |
| 54 | Lactic acidosis (HP:0003128) | 2.88314826 |
| 55 | Increased serum ferritin (HP:0003281) | 2.86271284 |
| 56 | Prolonged QT interval (HP:0001657) | 2.85135591 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.83946503 |
| 58 | Round ear (HP:0100830) | 2.80248428 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77782090 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.75270191 |
| 61 | Neck muscle weakness (HP:0000467) | 2.74844165 |
| 62 | Muscle stiffness (HP:0003552) | 2.74437982 |
| 63 | Respiratory failure (HP:0002878) | 2.74270215 |
| 64 | Left ventricular hypertrophy (HP:0001712) | 2.73627267 |
| 65 | Atrioventricular block (HP:0001678) | 2.71808986 |
| 66 | Cerebral edema (HP:0002181) | 2.70150249 |
| 67 | Heart block (HP:0012722) | 2.69275905 |
| 68 | Increased serum lactate (HP:0002151) | 2.62246395 |
| 69 | Paralysis (HP:0003470) | 2.58724149 |
| 70 | Nemaline bodies (HP:0003798) | 2.58495772 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.58384271 |
| 72 | Loss of speech (HP:0002371) | 2.57553539 |
| 73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.56282629 |
| 74 | Conjunctival hamartoma (HP:0100780) | 2.55838437 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51769864 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51769864 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51769864 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.51412312 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.50947811 |
| 80 | Hepatosplenomegaly (HP:0001433) | 2.49958585 |
| 81 | Rimmed vacuoles (HP:0003805) | 2.46898652 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.45321783 |
| 83 | Increased intramyocellular lipid droplets (HP:0012240) | 2.43799680 |
| 84 | Purpura (HP:0000979) | 2.43721532 |
| 85 | CNS demyelination (HP:0007305) | 2.43135027 |
| 86 | Neoplasm of the adrenal gland (HP:0100631) | 2.42961551 |
| 87 | Ulnar deviation of the wrist (HP:0003049) | 2.42659778 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.42330754 |
| 89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.42330754 |
| 90 | Multiple enchondromatosis (HP:0005701) | 2.37749043 |
| 91 | Limb-girdle muscle atrophy (HP:0003797) | 2.35292722 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.34483356 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34179833 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 2.32416667 |
| 95 | Palmoplantar keratoderma (HP:0000982) | 2.31267180 |
| 96 | Patent foramen ovale (HP:0001655) | 2.30220749 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.27423865 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27423865 |
| 99 | Malignant hyperthermia (HP:0002047) | 2.26895756 |
| 100 | Prolonged neonatal jaundice (HP:0006579) | 2.25862347 |
| 101 | Thrombocytosis (HP:0001894) | 2.25267106 |
| 102 | Mutism (HP:0002300) | 2.24918128 |
| 103 | Bulbar palsy (HP:0001283) | 2.23271762 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.21927330 |
| 105 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21696621 |
| 106 | Abnormality of alanine metabolism (HP:0010916) | 2.21241407 |
| 107 | Hyperalaninemia (HP:0003348) | 2.21241407 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21241407 |
| 109 | Renal Fanconi syndrome (HP:0001994) | 2.21026110 |
| 110 | Difficulty running (HP:0009046) | 2.19637536 |
| 111 | Achilles tendon contracture (HP:0001771) | 2.17468993 |
| 112 | Abnormality of complement system (HP:0005339) | 2.16722840 |
| 113 | Abnormal EKG (HP:0003115) | 2.15380344 |
| 114 | Ventricular fibrillation (HP:0001663) | 2.15300662 |
| 115 | Abnormality of the Achilles tendon (HP:0005109) | 2.14867272 |
| 116 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14464152 |
| 117 | Disinhibition (HP:0000734) | 2.13360180 |
| 118 | Nausea (HP:0002018) | 2.12631397 |
| 119 | Axonal loss (HP:0003447) | 2.12231064 |
| 120 | Hypoplastic left heart (HP:0004383) | 2.11919086 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11384619 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 2.11384619 |
| 123 | Joint stiffness (HP:0001387) | 2.06632575 |
| 124 | Distal lower limb amyotrophy (HP:0008944) | 2.06334820 |
| 125 | Testicular atrophy (HP:0000029) | 2.05162863 |
| 126 | Petechiae (HP:0000967) | 2.04953538 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 2.02589255 |
| 128 | Cholecystitis (HP:0001082) | 2.02589255 |
| 129 | Muscle fiber atrophy (HP:0100295) | 2.00351155 |
| 130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.99927824 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.99573779 |
| 132 | Difficulty climbing stairs (HP:0003551) | 1.99415387 |
| 133 | Ketoacidosis (HP:0001993) | 1.97900020 |
| 134 | Generalized muscle weakness (HP:0003324) | 1.94555914 |
| 135 | Hyperglycinuria (HP:0003108) | 1.94546436 |
| 136 | Pheochromocytoma (HP:0002666) | 1.93645779 |
| 137 | Retinal atrophy (HP:0001105) | 1.92954432 |
| 138 | Neuroendocrine neoplasm (HP:0100634) | 1.92329943 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 1.91867988 |
| 140 | Upper motor neuron abnormality (HP:0002127) | 1.90145780 |
| 141 | Abnormality of lateral ventricle (HP:0030047) | 1.89857155 |
| 142 | Microvesicular hepatic steatosis (HP:0001414) | 1.88989050 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.88910577 |
| 144 | Emotional lability (HP:0000712) | 1.88138431 |
| 145 | Frequent falls (HP:0002359) | 1.87576729 |
| 146 | Gowers sign (HP:0003391) | 1.85916829 |
| 147 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85547603 |
| 148 | Esophageal neoplasm (HP:0100751) | 1.84339585 |
| 149 | Neoplasm of head and neck (HP:0012288) | 1.84339585 |
| 150 | Congenital malformation of the right heart (HP:0011723) | 1.84171722 |
| 151 | Glomerulonephritis (HP:0000099) | 1.82996155 |
| 152 | Joint hemorrhage (HP:0005261) | 1.81010919 |
| 153 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80699967 |
| 154 | Myocardial infarction (HP:0001658) | 1.78261185 |
| 155 | Xanthomatosis (HP:0000991) | 1.77979149 |
| 156 | Vertebral compression fractures (HP:0002953) | 1.76957785 |
| 157 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76608017 |
| 158 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74411578 |
| 159 | Deep venous thrombosis (HP:0002625) | 1.73744750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.49381301 |
| 2 | MYLK | 5.39348973 |
| 3 | TTN | 4.80069723 |
| 4 | TAOK2 | 3.42682496 |
| 5 | NEK1 | 3.34086139 |
| 6 | ZAK | 2.95667575 |
| 7 | PHKG1 | 2.82641222 |
| 8 | PHKG2 | 2.82641222 |
| 9 | VRK2 | 2.82027181 |
| 10 | PKN2 | 2.70422481 |
| 11 | PRPF4B | 2.53178063 |
| 12 | STK24 | 2.40269123 |
| 13 | PIK3CA | 2.29916399 |
| 14 | BUB1 | 2.19573323 |
| 15 | BCKDK | 2.10906719 |
| 16 | PDK3 | 1.98622976 |
| 17 | PDK4 | 1.98622976 |
| 18 | NME2 | 1.94932905 |
| 19 | DDR2 | 1.92708013 |
| 20 | TAOK1 | 1.83111662 |
| 21 | EIF2AK1 | 1.81973929 |
| 22 | MUSK | 1.75984963 |
| 23 | CDK19 | 1.68015896 |
| 24 | PLK4 | 1.64649501 |
| 25 | STK38L | 1.62554879 |
| 26 | LIMK1 | 1.61676432 |
| 27 | PDK2 | 1.42395063 |
| 28 | PBK | 1.37908942 |
| 29 | TESK1 | 1.36560777 |
| 30 | MAP2K3 | 1.35522434 |
| 31 | SMG1 | 1.34659799 |
| 32 | IKBKB | 1.34332366 |
| 33 | DAPK3 | 1.32673428 |
| 34 | PINK1 | 1.30079112 |
| 35 | NME1 | 1.30077390 |
| 36 | TRIB3 | 1.28206849 |
| 37 | KDR | 1.26809493 |
| 38 | FLT3 | 1.26702336 |
| 39 | MATK | 1.20811981 |
| 40 | EEF2K | 1.15010345 |
| 41 | MAPKAPK5 | 1.13910222 |
| 42 | DMPK | 1.13301131 |
| 43 | MAPK12 | 1.12933010 |
| 44 | BRSK2 | 1.07920648 |
| 45 | BLK | 1.07328302 |
| 46 | LMTK2 | 1.05078769 |
| 47 | ICK | 1.04299063 |
| 48 | WEE1 | 1.02295680 |
| 49 | STK4 | 1.02226856 |
| 50 | ILK | 0.98689643 |
| 51 | SIK1 | 0.94048983 |
| 52 | BRAF | 0.86246136 |
| 53 | MOS | 0.84197412 |
| 54 | PKN1 | 0.82891033 |
| 55 | DYRK1B | 0.82524274 |
| 56 | IRAK2 | 0.78042731 |
| 57 | PAK3 | 0.77784922 |
| 58 | ARAF | 0.77043406 |
| 59 | CDC42BPA | 0.76045491 |
| 60 | MAP3K1 | 0.75155108 |
| 61 | TIE1 | 0.74541100 |
| 62 | MAP3K12 | 0.74400556 |
| 63 | PRKD2 | 0.73653790 |
| 64 | RPS6KL1 | 0.72943171 |
| 65 | RPS6KC1 | 0.72943171 |
| 66 | MAP3K14 | 0.72834126 |
| 67 | MAP3K3 | 0.71750828 |
| 68 | CDK8 | 0.70035456 |
| 69 | ACVR1B | 0.68905920 |
| 70 | TRPM7 | 0.67803784 |
| 71 | CAMK2D | 0.67422033 |
| 72 | NEK9 | 0.65630213 |
| 73 | ROCK1 | 0.65360872 |
| 74 | PRKAA1 | 0.64182930 |
| 75 | ABL2 | 0.63521723 |
| 76 | TESK2 | 0.63343397 |
| 77 | MAPK11 | 0.62654197 |
| 78 | MAP3K10 | 0.62553574 |
| 79 | RPS6KA6 | 0.62357516 |
| 80 | MAP3K5 | 0.61717537 |
| 81 | BRSK1 | 0.61366057 |
| 82 | PTK2B | 0.61268049 |
| 83 | AKT2 | 0.60759439 |
| 84 | RIPK1 | 0.60623563 |
| 85 | JAK3 | 0.60306145 |
| 86 | PIM2 | 0.60074456 |
| 87 | PRKD1 | 0.58003559 |
| 88 | IRAK3 | 0.55934809 |
| 89 | IRAK4 | 0.55472024 |
| 90 | GRK7 | 0.55146866 |
| 91 | FGR | 0.53568508 |
| 92 | CHUK | 0.52363455 |
| 93 | STK16 | 0.51274930 |
| 94 | CDK6 | 0.50978716 |
| 95 | MAP3K11 | 0.50918692 |
| 96 | ERN1 | 0.48972540 |
| 97 | CDK9 | 0.48128140 |
| 98 | PRKAA2 | 0.48105228 |
| 99 | PAK2 | 0.47263056 |
| 100 | VRK1 | 0.46190333 |
| 101 | AURKB | 0.46023279 |
| 102 | SRPK1 | 0.43919509 |
| 103 | CDK11A | 0.43907695 |
| 104 | DAPK1 | 0.43710281 |
| 105 | MAP4K1 | 0.43354138 |
| 106 | PIK3CG | 0.42920079 |
| 107 | CSF1R | 0.42434226 |
| 108 | PAK4 | 0.40148480 |
| 109 | TSSK6 | 0.40014198 |
| 110 | FGFR4 | 0.39989269 |
| 111 | TYK2 | 0.39630715 |
| 112 | SYK | 0.39371220 |
| 113 | EIF2AK3 | 0.38586835 |
| 114 | MARK3 | 0.38432652 |
| 115 | CDK4 | 0.37402273 |
| 116 | RPS6KA5 | 0.37184033 |
| 117 | ADRBK2 | 0.37089679 |
| 118 | TGFBR2 | 0.36701788 |
| 119 | BMX | 0.36495597 |
| 120 | PRKACB | 0.36421207 |
| 121 | NEK2 | 0.34834474 |
| 122 | PDPK1 | 0.34420271 |
| 123 | CDK15 | 0.34170539 |
| 124 | MAP2K6 | 0.34020204 |
| 125 | MAPK4 | 0.33903664 |
| 126 | KIT | 0.33723094 |
| 127 | MARK2 | 0.32539536 |
| 128 | LYN | 0.32277180 |
| 129 | PLK2 | 0.32108383 |
| 130 | CAMK2G | 0.31859346 |
| 131 | CAMK1 | 0.31488505 |
| 132 | CLK1 | 0.31079105 |
| 133 | CHEK2 | 0.31021557 |
| 134 | TEC | 0.30007083 |
| 135 | AURKA | 0.29461332 |
| 136 | CAMKK2 | 0.29010550 |
| 137 | ROCK2 | 0.28977747 |
| 138 | TGFBR1 | 0.28923879 |
| 139 | CSNK2A1 | 0.28396123 |
| 140 | IKBKE | 0.28254281 |
| 141 | PIM1 | 0.28103763 |
| 142 | TBK1 | 0.27513412 |
| 143 | PRKACA | 0.27279423 |
| 144 | ITK | 0.26588559 |
| 145 | MAPKAPK3 | 0.24395022 |
| 146 | EIF2AK2 | 0.24391066 |
| 147 | PLK1 | 0.21609309 |
| 148 | PAK1 | 0.20617042 |
| 149 | LRRK2 | 0.19871709 |
| 150 | CCNB1 | 0.18031050 |
| 151 | PRKACG | 0.17889349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.20506957 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.33170097 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.04186178 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 4.02742849 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.69276773 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.22034755 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.99071060 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.83616869 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.76843015 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.73438820 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.70437311 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.47256128 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25839630 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20513472 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14802849 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14721234 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09748609 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.98724985 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.88913052 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.87305787 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.81131178 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72857482 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72259898 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70401931 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.67522282 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66768045 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60419663 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56412196 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54813189 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52626293 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45787691 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43418697 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.40786161 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.32511828 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32473198 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.30758394 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27080178 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.25529050 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.22856055 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18892068 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18850410 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16592058 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15345699 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.06701671 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.05596535 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01380624 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98248276 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96135103 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95315006 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 0.93078940 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92125968 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91034605 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88249028 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.87861995 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87715275 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.86454258 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85379317 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84537964 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83978155 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83546191 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.81291147 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.80763803 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79580709 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79255775 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77946271 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77773127 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73862471 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73794936 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73349361 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72429930 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71913078 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70821113 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.70362021 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67849881 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67450816 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.66470559 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66182480 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 0.64848163 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.63664034 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60902547 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60007410 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58182144 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57239430 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57026782 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.56776031 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.55495379 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54519911 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54267605 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52162260 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50764451 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50716127 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.48558268 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48538292 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47542508 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46837134 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45720850 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45333442 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44502158 |
| 99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39803475 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37928712 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36525840 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36409262 |
| 103 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36297836 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35266769 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34949558 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34840319 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34585022 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33488153 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33001768 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32216024 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31024028 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24871249 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24059826 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23917268 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.22525846 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22289669 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.21004882 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.20966091 |
| 119 | Cell cycle_Homo sapiens_hsa04110 | 0.20008806 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18948369 |
| 121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18444406 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.15960486 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.13958316 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.13820437 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13760889 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.13583913 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.13507616 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10683488 |
| 129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.10545496 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.09973822 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.09703487 |
| 132 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.07142738 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05198390 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.04739661 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04475093 |
| 136 | Protein export_Homo sapiens_hsa03060 | 0.04271320 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04049172 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.03596121 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.03174851 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02927505 |

